Mankind Pharma expands its OTC portfolio by launching ‘Health OK’ tablets : Mankind Pharma has been actively expanding its OTC[1] range of products these days. Recently, this pharma company incorporated a new product called ‘Health OK’ tablets under its OTC portfolio. This is a multivitamin tablet and food supplement. The company claimed that ‘Health OK’ […]
Zydus Cadila and Alembic Pharma initiate a nationwide recall of 2 drugs in the US following complaints : The US[1] health regulator, USFDA[2], has recently posted two separate announcements on its website. These announcements state the voluntary recall of some products by two major pharma firms in the US. The two pharma firms that have
Zydus and Alembic initiate a recall of 2 drugs in the US Read More »
Sun Pharma and Cadila, along with two other pharma firms, invest around Rs. 40 crore each in ABCD Technologies : Four drug majors have recently announced that they have subscribed to partnership interest in a healthcare services firm. The drug majors involved are Sun Pharma, Cadila Healthcare, Lupin, and Torrent Pharma. These companies have invested
Why Indian Pharma investing in IndoHealth Services? Read More »
Aleor Dermaceuticals, a joint venture of Alembic Pharma gets the USFDA approval for its generic antifungal cream : On 1 April 2021, Alembic Pharma made an announcement regarding its joint venture Aleor Dermaceuticals. It stated that the latter had received the USFDA’s[1] approval for a generic antifungal cream. This generic version contains Nystatin and Triamcinolone
Biocon Pharma and Libbs Farmaceutica collaborate to launch generic drugs in Brazil : Biocon Pharma is a wholly–owned subsidiary of Biocon. This pharma has recently entered into a partnership with Libbs Farmaceutica. The latter is a leading pharmaceutical company in Brazil. This partnership motive is to assist Biocon in the launch of generic drugs in
Cadila settles litigation with Celgene over patents for the anti-cancer drug Revlimid Cadila Healthcare and its subsidiary Zydus Pharmaceuticals Inc. have reached a settlement with Celgene Corporation on 24 March 2021. This settlement was done over the patents for the anti–cancer drug Revlimid. Per this agreement, both parties will file consent judgments with the US
Cadila settles litigation with Celgene over Revlimid Read More »
Glenmark Pharma becomes first domestic drugmaker to get a USD 40 million COVID loans from IFC : Glenmark Pharma has secured a USD[1] 40 million ( about Rs. 290 crores ) credit – line from IFC’s[2] USD 8 billion fast–track COVID – 19 facility. This has made the drug firm the first domestic one to
Brief Profile : The USFDA or FDA is a federal agency formed in 1906, making it the oldest comprehensive consumer protection agency. As the name suggests, this is an agency within the Department of Health and Human Services. This agency’s headquarters is at White Oak, Maryland, and it is headed by the United States Commissioner
Glenmark gets first applicant approval for its diltiazem hydrochloride capsules from USFDA : Glenmark Pharma recently announced its diltiazem hydrochloride’s approval for extended–release capsules by USFDA, as per the reports made public on 23 March 2021 [1]. Read the story behind Glenmark’s diltiazem capsules. The product is the generic version of Cardizem SR[1] extended–release capsules,
Stelis Pharma partners with Russia’s sovereign wealth fund to supply 200 million doses of Sputnik V for India Stride Pharma’s subsidiary Stelis Biopharma has partnered with Russia’s sovereign wealth fund regarding Sputnik V production. This collaboration aims to produce and supply over 200 million doses of the COVID – 19 vaccines for India. Strides Pharma
